Table 1.
Characteristics of the study sample
| Total | Study group | Control group | p | |
|---|---|---|---|---|
| Gender female/male | 20/8 | 9/5 | 11/3 | 0.40a |
| Mean age (years, SD) | 47.5 (9.3) | 49.0 (7.1) | 46.1 (11.2) | 0.47b |
| Mean education (years, SD) | 11.7 (3.4) | 12.8 (3.1) | 10.7 (3.5) | 0.14b |
| Mean age at onset (years, SD) | 30.2 (11.2) | 29.1 (8.2) | 31.29 (13.8) | 0.63b |
| Mean disease duration (years, SD) | 14.5 (9.4) | 16.6 (8.6) | 10.4 (6.6) | 0.31b |
| Disease course RR/SP | 17/11 | 8/6 | 9/5 | 0.70a |
| EDSS (mean, SD) | 3.8 (1.9) | 3.6 (1.6) | 4.1 (2.3) | 0.55b |
| Treatment with DMD (#, %) | 18 (64.2) | 8 (57.1) | 10 (71.4) | 0.43a |
Abbreviations: SD standard deviations, RR relapsing-remitting, SP secondary progressive DMD disease-modifying drugs
Reported p values refer to: aPearson’s Chi Square test for categorical variables; b Student's t-test for continuous variables